• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The role of autophagy in severe influenza-related pneumonia

Research Project

Project/Area Number 15K19587
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Infectious disease medicine
Research InstitutionNagasaki University

Principal Investigator

KOSAI Kosuke  長崎大学, 病院(医学系), 助教 (70644433)

Research Collaborator YANAGIHARA Katsunori  長崎大学, 医歯薬学総合研究科(医学系), 教授 (40315239)
MORINAGA Yoshitomo  長崎大学, 医歯薬学総合研究科(医学系), 助教 (30580360)
Project Period (FY) 2015-04-01 – 2018-03-31
Project Status Completed (Fiscal Year 2017)
Budget Amount *help
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2017: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2016: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2015: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Keywordsインフルエンザウイルス / 肺炎球菌 / オートファジー / オートファジー阻害薬
Outline of Final Research Achievements

We analyzed the role of autophagy in severe influenza-related bacterial pneumonia. In vitro studies showed that the number of A549 cells expressing autophagic vesicle increased during coinfection in a time-dependent manner, and decreased after they peaked. The expression of LC3B in inflammatory cells increased in coinfected mice, compared to uninfected mice. Autophagy inhibitor suppressed the gene and protein expression of interleukin (IL)-6 in coinfection in vitro, whereas it enhanced the expression of matrix metalloproteinase (MMP)-10. Autophagy may be involved in mechanisms of severe influenza-related bacterial pneumonia.

Report

(4 results)
  • 2017 Annual Research Report   Final Research Report ( PDF )
  • 2016 Research-status Report
  • 2015 Research-status Report
  • Research Products

    (1 results)

All 2016

All Journal Article (1 results) (of which Peer Reviewed: 1 results,  Open Access: 1 results)

  • [Journal Article] Premedication with clarithromycin is effective against secondary bacterial pneumonia during influenza virus infection in a pulmonary emphysema mouse model.2016

    • Author(s)
      Harada T, Ishimatsu Y, Hara A, Morita T, Nakashima S, Kakugawa T, Sakamoto N, Kosai Y, Izumikawa K, Yanagihara K, Mukae H, Kohno S
    • Journal Title

      J Pharmacol Exp Ther

      Volume: 358 Issue: 3 Pages: 457-463

    • DOI

      10.1124/jpet.116.233932

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access

URL: 

Published: 2015-04-16   Modified: 2019-03-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi